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INTRODUCTION
Latent autoimmune diabetes of the adult
(LADA) as originally described represents
perhaps as many as 10 – 20% of adult-onset
patients with diabetes.1 This slow
autoimmune form of type 1 diabetes has been
reported in the majority of Caucasian
populations.2-4 As far as we know, there is no
report in the literature regarding LADA in a
native Indian population from anywhere in
the world.5 We here report the first case of
LADA in a Brazilian Indian.
We have prospectively evaluated all 15 di-
agnosed diabetic patients from a Brazilian In-
dian community composed of 1000 individu-
als (336 adults). The majority of these 15 pa-
tients are obese and all of them exhibited the
clinical course of type 2 diabetes.6 So far, they
have been treated with diet and oral anti-dia-
betic agents.
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CASE REPORT
We describe the case of a male 38-year-old
Xavante-Jê Indian from the western groups of
the Sangradouro community in Poxoréu, Mato
Grosso, Brazil. About five years ago, he was di-
agnosed with diabetes symptoms (polyuria,
polydipsia, polyphagia and weight loss) with a
fasting plasma glucose (FPG) level of 22.2
mmol/L. After being treated with chlorpropa-
mide for a period of 18 months, he started los-
ing weight and presented with worsening of
symptoms of diabetes followed by signs of ke-
tosis. Insulin treatment was then initiated.
At this time arterial blood pressure (BP: 110
x 80 mmHg) or lipidemia (total cholesterol:
28.7 mmol/L and triglycerides: 1.16 nmol/L)
were normal but he had a previous history of
obesity (BMI > 27 Kg/m2). Anti-GAD
65
 was
4.1 U/ml (cut-off = 1.00 U/ml) using a radio-
immunoassay kit with human recombinant I125
GAD
65
 from Kronus® and IA-2 antibodies were
0.01 U/ml (cutoff = 0.47 U/ml) using a radio-
immunoassay kit with human recombinant I125
IA-2 from Kronus®. The fasting C-peptide level
was 0.19 nmol/L (Normal range: 0.11 – 1.18
nmol/L). Recently, the fasting plasma glucose
level has varied between 5.9 and 7.2 mmol/L
with 50 U of NPH insulin a day.
Macroproteinuria and diabetic retinopathy have
not been detected.
There is a family history of diabetes that
includes an obese sibling who has been treated
with diet and oral anti-diabetic agent.
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DISCUSSION
As is known, the usual features of LADA
patients are: onset of diabetes at > 25 years of
age, clinical presentation masquerading as
type 2 diabetes, initial control of
hyperglycemia with diet and oral anti-diabetic
agents, evolution to insulin necessity within
months and some features of type 1 diabetes
such as low fasting C-peptide and positive
anti-GAD antibodies.7 Our patient shared all
those characteristics (with age > 35 years at
onset of diabetes, he had been non-ketotic
and non-insulin dependent for 6 months and
insulin deficiency was demonstrated by low
serum fasting C-peptide).
Anti-GAD antibodies can be detected in
about 10% of type 2 diabetic patients.8 How-
ever this antibody is more frequent (73.7%) in
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CONTEXT: Latent autoimmune diabetes of the adult
(LADA) as originally described represents perhaps
as many as 10 – 20% of adult-onset patients with
diabetes.
DESIGN: case report.
CASE REPORT: A 38-year-old Brazilian Xavante-Jê In-
dian with Latent Autoimmune Diabetes of the Adult
(LADA) is described, coming from the Sangradouro
community in Poxoréu, Mato Grosso. The onset of
diabetes after reaching 25 years of age, the evolu-
tion to insulin deficiency after a period of insulin-
independence and the presence of auto-antibodies
to glutamic acid decarboxylase (GAD) characteris-
tic of LADA were present. This patient may repre-
sent the first case of LADA in a Brazilian with full
Indian heritage. Further studies are necessary to
verify the prevalence of this new type of diabetes in
this population that does not have Caucasoid ad-
mixture and has a particular environmental back-
ground.
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these patients when they present LADA fea-
tures.9 The low prevalence of IA2 antibodies, as
compared with anti-GAD, that has been shown
in these patients, can help to explain the lack of
CONTEXTO: O diabetes auto-imune do adulto,
como originalmente escrito, representa 10 a
20% dos doentes diabéticos que iniciam a
doença.
TIPO DE ESTUDO: Relato de caso.
RELATO DO CASO: Um índio de 38 anos, do grupo
Xavante Jê, pertencente a comunidade de
Sangradouro, Poxoréu, Mato-Grosso, Brasil, com
Diabetes Auto-imune Latente do Adulto (LADA)
é descrito. Início do quadro clínico de diabetes
após os 25 anos, evolução para deficiência
insulínica após um período de insulino-
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independência e presença de auto-anticorpos anti-
GAD circulantes, características do LADA estão
presentes. Esse é o primeiro caso de LADA
descrito em populações indígenas. A extensão do
estudo é necessária para verificar a prevalência
desse novo tipo de diabetes nessa população que
não possui componente genético caucasóide e
apresenta condições ambientais próprias. Essa
caracterização é importante para o diagnóstico,
tratamento e prognóstico desses indivíduos.
PALAVRAS-CHAVE : Diabetes Autoimune
Latente do Adulto. Índio. Brasileiro.
this antibody in our patient.
In summary, this patient may represent the
first case of LADA3 in a Brazilian with full In-
dian heritage. Further studies are necessary to
verify the prevalence of this new type of diabe-
tes in this population that does not have
Caucasoid genetic admixture and has a particu-
lar environmental background.
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